What We Have Learnt: A Decade of Hematopoietic Stem Cell Transplantation (HSCT) for Acute Myeloid Leukaemia (AML) in Lower Middle Income Countries (LMIC) Settings.

Puntos clave

• Hematopoietic stem cell transplantation shows promising outcomes for acute myeloid leukemia.
• Survival rates have improved over the last decade, with a notable increase in success.
• Observational analysis across multiple lower middle income countries highlights regional disparities in transplantation.
• The findings indicate a need for better resources and support for transplantation in LMICs.